Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$495,525
-$195,942 QoQ
Shares Held
39,234
-10.5% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Man Group plc holds $1,080,100,046 across 125 Biotechnology names. ENTA ranks #92 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
315,212 | $243,545,399 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
236,798 | $105,739,778 | |
| 3 | INCY |
Incyte Corp
|
930,171 | $87,547,693 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
232,369 | $76,883,931 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
241,922 | $71,843,576 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
915,689 | $36,838,167 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
275,270 | $26,770,006 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
135,212 | $25,561,828 |
All Filings in ENTA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $495,525 | 39,234 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $691,467 | 43,847 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $480,667 | 40,156 | Shares | Defined | 2025-11-14 | |
| 2023-12-31 | $399,125 | 42,415 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $637,230 | 13,698 | Shares | Defined | 2023-02-14 | |
| 2020-12-31 | $7,463,824 | 177,288 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,704,279 | 233,820 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,551,967 | 170,324 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $10,111,395 | 196,605 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||